372492009: Phenylbutylpiperadine derivative antipsychotic agent (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1197785012 Phenylbutylpiperadine derivative antipsychotic agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1211027011 Phenylbutylpiperadine derivative antipsychotic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Phenylbutylpiperadine derivative antipsychotic agent	Is a	Anti-psychotic agent (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing haloperidol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Phenylbutylpiperadine derivative antipsychotic agent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol [antipsychotic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 1.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 2mg/5mL s/f oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 1mg/5mL s/f oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 500 microgram oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 1 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
halopéridol 10 mg/mL, ampoule de 2 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 1.5mg/5mL s/f oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
décanoate d'halopéridol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol [tics, chorea] [see D47..]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Product containing haloperidol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol decanoate 50mg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 0.5mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 100mg injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 5mg injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Oral form haloperidol solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Haloperidol (substance)	Is a	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some
Trifluperidol (substance)	Is a	False	Phenylbutylpiperadine derivative antipsychotic agent	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1197785012	Phenylbutylpiperadine derivative antipsychotic agent (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211027011	Phenylbutylpiperadine derivative antipsychotic agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core